Medication management and neuropsychological performance in Parkinson's disease

Clinical Neuropsychologist

Volumn 26, Issue 1, 2012, Pages 45-58

  Manning, Kevin J ^a,b   Clarke, Christina ^c   Lorry, Alan ^d   Weintraub, Daniel ^b,d   Wilkinson, Jayne R ^b,d   Duda, John E ^b,d   Moberg, Paul J ^b,d  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; Instrumental activities of daily living; Medication management; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; HUMAN; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SELF REPORT; STATISTICS;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; SELF REPORT; STATISTICS AS TOPIC;

EID: 84858179301     PISSN: 13854046     EISSN: 17444144     Source Type: Journal    
DOI: 10.1080/13854046.2011.639312     Document Type: Article

References (31)

1. Allaire, J. C., & Marsiske, M. (1999). Everyday cognition: Age and intellectual ability correlates. Psychology of Aging, 14, 627-644. (Pubitemid 30043364)
2. Army Individual Test Battery (1944). Manual for directions and scoring. Washington, DC: War Department, Adjutant General's Office.
3. Bainbridge, J. L., & Ruscin, J. M. (2009). Challenges of treatment adherence in older patients with Parkinson's disease. Drugs Aging, 26, 145-155.
4. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful appraoch to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological), 57, 289-300.
5. Brandt, J., & Benedict, R. H. (2001). Hopkins Verbal Learning Test-Revised. Professional Manual. Lutz, FL: Psychological Assessment Resources.
6. Carlson, M. C., Fried, L. P., Xue, Q. L., Tekwe, C., & Brandt, J. (2005). Validation of the Hopkins Medication Schedule to identify difficulties in taking medications. The Journals of Gerontolology. Series A, Biological Sciences and Medical Sciences, 60, 217-223. (Pubitemid 40524863)
7. Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates Inc.
8. Davis, K. L., Edin, H. M., & Allen, J. K. (2010). Prevalence and cost of medication nonadherence in Parkinson's diease: Evidence from administrative claims data. Movement Disorders, 25, 474-480.
9. Doggrell, S. A. (2010). Adherence to medicines in the older-aged with chronic conditions: Does intervention by an allied health professional help? Drugs and Aging, 27, 239-254.
10. Fahn, S., & Elton, R. L. (1987). Unified Parkinson's Disease Rating Scale. In S. Fahn, C. D. Marsden, D. Calne, & M. Goldstein (Eds.), Recent developments in Parkinson's disease (pp. 153-164). Florham Park, NJ: Macmillan.
11. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini mental state": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research, 12, 189-198.
12. Goldberg, T. E., Koppel, J., Keehlisen, L., Christen, E., Dreses-Werringloer, U., Conejero- Goldberg, C., et al. (2010). Performance-based measures of everyday function in mild cognitive impairment. American Journal of Psychiatry, 167, 845-853.
13. Grosset, D., Antonini, A., Canesi, M., Pezzoli, G., Lees, A., Shaw, K., et al. (2009). Adherence to antiparkinson medication in a multicenter European study. Movement Disorders, 24, 826-832.
14. Grosset, K. A., Bone, I., & Grosset, D. G. (2005). Suboptimal medication adherence in Parkinson's disease. Movement Disorders, 20, 1502-1507. (Pubitemid 43072661)
15. Hayes, T. L., Larimer, N., Adami, A., & Kaye, J. A. (2009). Medication adherence in healthy elders: Small cognitive changes make a big difference. Journal of Aging and Health, 21, 567-580.
16. Heaton, R. K., Miller, S. W., Taylor, M. J., & Grant, I. (2004). Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources.
17. Hoops, S., Nazem, S., Siderowf, A. D., Duda, J. E., Xie, S. X., Stern, M. B., et al. (2009). Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology, 73, 1738-1745.
18. Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. Journal of Neurology Neurosurgery and Psychiatry, 55, 181-184.
19. Jurica, P., Leitten, C., & Mattis, S. (2001). Dementia Rating Scale-2. Lutz, FL: Psychological Assessment Resources Inc.
20. Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010). Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurology, 9, 1200-1213.
21. Kongs, S. K., Thompson, L. L., Iverson, G., & Heaton, R. K. (2000). Wisconsin Card Sorting Test-64 card version (WCST-64) professional manual. Lutz, FL: Psychological Assessment Resources.
22. Lafayette Instruments (2002). Grooved Pegboard user instructions. Lafayette, IN: Lafayette Instrument.
23. Leopold, N. A., Polansky, M., & Hurka, M. R. (2004). Drug adherence in Parkinson's disease. Movement Disorders, 19, 513-517.
24. Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., et al. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatric Society, 53, 695-699. (Pubitemid 41623495)
25. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487-497. (Pubitemid 41127293)
26. Rosenthal, E., Brennan, L., Xie, S. X., Hurtig, H., Milber, J., Weintraub, D., et al. (2010). Association between cognition and function in patients with Parkinson disease with and without dementia. Movement Disorders, 25, 1170-1176.
27. Steinman, M. A., & Hanlon, J. T. (2010). Managing medications in clinically complex elders: "There's got to be a happy medium". Journal of the American Medical Association, 304, 1592-1601.
28. Wechsler, D. (1997). Wechsler Adult Intelligence Scale (3rd ed.). San Antonio, TX: Psychological Corportation.
29. Weintraub, D. (2009). Impulse control disorder's in Parkinson's disease: Prevalence and possible risk factors. Parkinson's Disease and Related Disorders, 15(Suppl 3), 110-113.
30. Weintraub, D., Cornella, C. L., & Horn, S. (2008). Parkinson's disease-Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment. The American Journal of Managed Care, 2008, S40-S48. (Pubitemid 351451787)
31. Young, T. L., Granic, A., Yu Chen, T., Haley, C. B., & Edwards, J. D. (2010). Everyday reasoning abilities in persons with Parkinson's disease. Movement Disorders, 25, 2756-2761.